CVS and Walgreens Have Wasted More Vaccine Doses Than Most States Combined

Two national pharmacy chains that the federal government entrusted to inoculate people against covid-19 account for the lion’s share of wasted vaccine doses, according to government data obtained by KHN. The Centers for Disease Control and Prevention recorded 182,874 wasted doses as of late March, three months into the country’s effort to vaccinate the masses against the coronavirus. Of those, […]

Read more

U.S. FDA Approves Yescarta for Relapsed or Refractory Follicular Lymphoma After Two or More Lines of Systemic Therapy

SANTA MONICA, Calif.–(BUSINESS WIRE)–Mar. 5, 2021– Kite, a Gilead Company (Nasdaq: GILD), today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval to Yescarta® (axicabtagene ciloleucel) for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL) after two or more lines of systemic therapy. The approval makes Yescarta the first chimeric antigen receptor (CAR) T-cell therapy approved for […]

Read more

Humira (adalimumab) Receives FDA Approval to Treat Pediatric Patients Living with Moderately to Severely Active Ulcerative Colitis

NORTH CHICAGO, Ill., Feb. 24, 2021 /PRNewswire/ — AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) approved Humira (adalimumab) for the treatment of moderately to severely active ulcerative colitis in pediatric patients 5 years of age and older. In clinical trials, Humira induced clinical remission at Week 8 and maintained remission at Week 52 in […]

Read more

FDA Approves Posimir

FDA Approves Posimir (bupivacaine) for Post-Surgical Pain Reduction for up to 72 Hours Following Arthroscopic Subacromial Decompression CUPERTINO, Calif., Feb. 2, 2021 /PRNewswire/ — DURECT Corporation (Nasdaq: DRRX) today announced that the U.S. Food and Drug Administration (FDA) has approved Posimir (bupivacaine solution) for infiltration use in adults for administration into the subacromial space under direct arthroscopic visualization to produce […]

Read more

Avodart

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. AVODART® (Dutasteride) Consumer Medicine Information What is in this leaflet? Please read this leaflet carefully before you take AVODART. This leaflet answers some common questions about AVODART.It does not contain all of the available information. It does not take the place of talking to your doctor or […]

Read more

Terry White Chemists Amitriptyline

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. Terry White Chemists Amitriptyline Tablets Contains the active ingredient amitriptyline (as hydrochloride) Consumer Medicine Information What is in this leaflet Read this leaflet carefully before taking your medicine. This leaflet answers some common questions about amitriptyline. It does not contain all the available information. It does not […]

Read more

Livostin

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. LIVOSTIN® Eye Drops and Nasal Spray Levocabastine Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about LIVOSTIN. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have […]

Read more

Firmagon

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. Firmagon® Degarelix (as acetate) Powder and Solvent for Injection, depot Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Firmagon. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. […]

Read more

Elelyso

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ELELYSO® taliglucerase alfa rpc Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Elelyso. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. […]

Read more
1 2 3 15